We are live on ! Find out more
Federated Hermes

Federated Hermes Portfolio holdings

AUM $61.5B
1-Year Est. Return 30.7%
This Fund
S&P 500
This Quarter Est. Return
+1.34%
1 Year Est. Return
+30.7%
3 Year Est. Return
+96.89%
5 Year Est. Return
+121.97%
10 Year Est. Return
+542.41%
AUM
$42.2B
AUM Growth
-$1.23B
Cap. Flow
-$952M
Cap. Flow %
-2.26%
Top 10 Hldgs %
14.57%
Holding
2,171
New
150
Increased
772
Reduced
960
Closed
152

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$156M
2
PLD icon
Prologis
PLD
+$150M
3
CVX icon
Chevron
CVX
+$109M
4
QCOM icon
Qualcomm
QCOM
+$101M
5
PAYC icon
Paycom
PAYC
+$90.8M

Sector Composition

Rank Sector Weight
1 Technology 18.81%
2 Healthcare 17.11%
3 Financials 12.73%
4 Industrials 9.92%
5 Consumer Discretionary 9.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VST icon
76
Vistra
VST
$48.5B
$122M 0.29%
1,422,111
-481,751
-25% -$40.3M
OWL icon
77
Blue Owl Capital
OWL
$6.44B
$121M 0.29%
6,817,200
-156,300
-2% -$2.87M
PRU icon
78
Prudential Financial
PRU
$43B
$120M 0.28%
1,025,527
+82,620
+9% +$9.54M
IBN icon
79
ICICI Bank
IBN
$108B
$119M 0.28%
4,145,436
+435,273
+12% +$11.7M
TRP icon
80
TC Energy
TRP
$70.7B
$117M 0.28%
3,100,034
-261,535
-8% -$9.92M
DHR icon
81
Danaher
DHR
$142B
$117M 0.28%
469,140
-48,016
-9% -$12.1M
COF icon
82
Capital One
COF
$130B
$116M 0.28%
838,344
-34,313
-4% -$4.81M
BCE icon
83
BCE
BCE
$20.7B
$115M 0.27%
3,564,393
+186,659
+6% +$6.22M
EXP icon
84
Eagle Materials
EXP
$6.57B
$115M 0.27%
529,701
+132,677
+33% +$32.5M
ARCT icon
85
Arcturus Therapeutics
ARCT
$161M
$114M 0.27%
4,694,060
-1,312
-0% -$39.8K
O icon
86
Realty Income
O
$61.5B
$113M 0.27%
2,140,696
+755,987
+55% +$40.4M
CAMT icon
87
Camtek
CAMT
$6.04B
$113M 0.27%
902,525
-9,518
-1% -$909K
SHW icon
88
Sherwin-Williams
SHW
$84.9B
$113M 0.27%
377,345
-1,825
-0.5% -$565K
JD icon
89
JD.com
JD
$43.3B
$111M 0.26%
4,280,215
+603,211
+16% +$17.7M
ZTS icon
90
Zoetis
ZTS
$33B
$110M 0.26%
635,204
-139
-0% -$23.1K
ARGX icon
91
argenx
ARGX
$55.2B
$109M 0.26%
254,390
-14,044
-5% -$5.38M
VEEV icon
92
Veeva Systems
VEEV
$33.8B
$108M 0.26%
592,187
+24,689
+4% +$4.9M
CMG icon
93
Chipotle Mexican Grill
CMG
$43.8B
$108M 0.26%
1,723,973
-44,827
-3% -$2.78M
ANET icon
94
Arista Networks
ANET
$201B
$107M 0.25%
1,225,832
-231,980
-16% -$17.2M
PG icon
95
Procter & Gamble
PG
$338B
$107M 0.25%
648,125
-231,296
-26% -$37.8M
TYL icon
96
Tyler Technologies
TYL
$14.2B
$104M 0.25%
206,644
-4,380
-2% -$2.02M
SPGI icon
97
S&P Global
SPGI
$123B
$102M 0.24%
229,786
-2,967
-1% -$1.27M
SHOP icon
98
Shopify
SHOP
$169B
$102M 0.24%
1,547,448
+7,319
+0.5% +$485K
BZ icon
99
Kanzhun
BZ
$7.25B
$101M 0.24%
5,368,870
+507,337
+10% +$10.2M
MELI icon
100
Mercado Libre
MELI
$94.4B
$101M 0.24%
61,432
+2,792
+5% +$4.41M

Similar funds

Federated Hermes's Q2 2024 Portfolio in Review

As of Q2 2024, Federated Hermes held 2,171 positions worth $42.2B, down 2.8% from $43.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Federated Hermes's Q2 2024 filing shows 150 new, 772 increased, 960 reduced and 152 closed positions. Its largest new stake was Loar Holdings: 729,296 shares worth $39M. The largest sale was Fusion Pharmaceuticals Inc. Common Shares, an estimated $230M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.

  • Federated Hermes's largest Q2 2024 buy was Loar Holdings: 729,296 shares worth $39M.
  • Federated Hermes added most to Bristol-Myers Squibb in Q2 2024, an estimated $156M increase.
  • Federated Hermes's biggest Q2 2024 reduction was Kimberly-Clark, cutting an estimated $160M.
  • Federated Hermes fully exited Fusion Pharmaceuticals Inc. Common Shares in Q2 2024, selling an estimated $230M.
  • Federated Hermes's ten largest holdings make up 15% of its $42.2B portfolio in Q2 2024.
  • Federated Hermes opened 150 new positions and closed 152 in Q2 2024.
  • Federated Hermes's portfolio value fell 2.8% quarter-over-quarter to $42.2B.

Based on Federated Hermes's 13F filing for Q2 2024, filed 8 Aug 2024.